• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病中的低血压和低血糖水平。代谢减退性疾病的证据?

Low blood pressure and blood glucose levels in Alzheimer's disease. Evidence for a hypometabolic disorder?

作者信息

Landin K, Blennow K, Wallin A, Gottfries C G

机构信息

Department of Medicine II, Sahlgrenska Hospital, Göteborg, Sweden.

出版信息

J Intern Med. 1993 Apr;233(4):357-63. doi: 10.1111/j.1365-2796.1993.tb00684.x.

DOI:10.1111/j.1365-2796.1993.tb00684.x
PMID:8463769
Abstract

OBJECTIVE

To test possible differences between patients with Alzheimer's disease (AD) and patients with other forms of dementia and the healthy population concerning body composition, blood pressure, metabolic data and leukoaraiosis (LA).

DESIGN

Retrospective study on data collected according to a predefined protocol.

SETTING

A geriatric, neuropsychiatric diagnostic unit.

SUBJECTS

Seventy-one consecutive patients with dementia.

MAIN OUTCOME MEASURES

Body mass index, blood pressure, metabolism and LA in AD compared to other dementia forms.

RESULTS

Mean blood pressure and fasting blood glucose levels were lower in patients with AD, 94 +/- 12 mmHg and 4.3 +/- 0.5 mmol l-1, compared to patients with unspecified dementia (NUD), 100 +/- 10 mmHg and 5.5 +/- 2.5 mmol l-1 (P < 0.05) and vascular dementia (VAD), 114 +/- 12 mmHg and 5.6 +/- 1.6 mmol l-1 (P < 0.001) and the age-matched healthy population. Body mass index, serum cholesterol and cortisol were similar in all groups of dementia patients whereas triglycerides were highest in the VAD group. No cases of diabetes or treatment for hypertension were found in the AD group while the prevalence was 21% and 36% for diabetes in the NUD and VAD groups and 8% in the population from the same region. There were 16% with antihypertensive treatment in dementia NUD, 50% in VAD, and 30% in the general population. Treated or newly detected hypothyreosis was present in 11% of the AD patients, none in the other dementia groups and 2% in the general population. Smoking was least common in AD. Degree of LA correlated with blood pressure and blood glucose levels.

CONCLUSIONS

AD was clearly different to other dementia patients. They had lower blood pressure, blood glucose and higher prevalence of hypothyreosis than the healthy, age-matched population. These findings may indicate that AD could be a hypometabolic disorder.

摘要

目的

检测阿尔茨海默病(AD)患者、其他形式痴呆患者以及健康人群在身体成分、血压、代谢数据和脑白质疏松(LA)方面可能存在的差异。

设计

根据预定义方案对收集的数据进行回顾性研究。

设置

一个老年神经精神诊断单元。

研究对象

71例连续的痴呆患者。

主要观察指标

将AD患者与其他痴呆形式患者的体重指数、血压、代谢和LA进行比较。

结果

与未明确类型痴呆(NUD)患者(收缩压100±10 mmHg,舒张压5.5±2.5 mmol/L)、血管性痴呆(VAD)患者(收缩压114±12 mmHg,舒张压5.6±1.6 mmol/L)以及年龄匹配的健康人群相比,AD患者的平均血压和空腹血糖水平较低,分别为94±12 mmHg和4.3±0.5 mmol/L(P<0.05)以及(P<0.001)。所有痴呆患者组的体重指数、血清胆固醇和皮质醇相似,而甘油三酯在VAD组中最高。AD组未发现糖尿病或高血压治疗病例,而NUD组和VAD组的糖尿病患病率分别为21%和36%,同一地区人群的患病率为8%。痴呆NUD组有16%接受抗高血压治疗,VAD组为50%,普通人群为30%。11%的AD患者存在经治疗或新检测出的甲状腺功能减退,其他痴呆组均无,普通人群为2%。AD患者吸烟最少见。LA程度与血压和血糖水平相关。

结论

AD与其他痴呆患者明显不同。与年龄匹配的健康人群相比,他们的血压、血糖较低,甲状腺功能减退患病率较高。这些发现可能表明AD可能是一种低代谢性疾病。

相似文献

1
Low blood pressure and blood glucose levels in Alzheimer's disease. Evidence for a hypometabolic disorder?阿尔茨海默病中的低血压和低血糖水平。代谢减退性疾病的证据?
J Intern Med. 1993 Apr;233(4):357-63. doi: 10.1111/j.1365-2796.1993.tb00684.x.
2
Differences in peripheral oxidative stress markers in Alzheimer's disease, vascular dementia and mixed dementia patients.阿尔茨海默病、血管性痴呆和混合性痴呆患者外周氧化应激标志物的差异。
Geriatr Gerontol Int. 2015 Dec;15 Suppl 1:53-8. doi: 10.1111/ggi.12659.
3
Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia.阿尔茨海默病和血管性痴呆患者血清对氧磷酶活性的变化
Eur Arch Psychiatry Clin Neurosci. 2002 Apr;252(2):63-7. doi: 10.1007/s004060200013.
4
Atherosclerosis, Hypertension, and Diabetes in Alzheimer's Disease, Vascular Dementia, and Mixed Dementia: Prevalence and Presentation.阿尔茨海默病、血管性痴呆和混合性痴呆中的动脉粥样硬化、高血压和糖尿病:患病率和表现。
J Alzheimers Dis. 2018;65(4):1247-1258. doi: 10.3233/JAD-180644.
5
Regulation of the hypothalamic-pituitary-adrenal axis in dementia disorders.痴呆症中下丘脑 - 垂体 - 肾上腺轴的调节
Ann N Y Acad Sci. 1994 Nov 30;746:336-43; discussion 343-4. doi: 10.1111/j.1749-6632.1994.tb39253.x.
6
Weight, blood pressure, osmolarity, and glucose levels across various stages of Alzheimer's disease and vascular dementia.阿尔茨海默病和血管性痴呆不同阶段的体重、血压、渗透压和血糖水平。
Dement Geriatr Cogn Disord. 1997 May-Jun;8(3):147-51. doi: 10.1159/000106623.
7
Lipids' peroxidation markers in Alzheimer's disease and vascular dementia.阿尔茨海默病和血管性痴呆中的脂质过氧化标志物。
Geriatr Gerontol Int. 2010 Apr;10(2):161-6. doi: 10.1111/j.1447-0594.2009.00571.x.
8
Uric Acid and High-Density Lipoprotein Cholesterol Are Differently Associated with Alzheimer's Disease and Vascular Dementia.尿酸和高密度脂蛋白胆固醇与阿尔茨海默病和血管性痴呆的相关性不同。
J Alzheimers Dis. 2020;73(3):1125-1131. doi: 10.3233/JAD-191111.
9
Can PET data differentiate Alzheimer's disease from vascular dementia?正电子发射断层扫描(PET)数据能区分阿尔茨海默病和血管性痴呆吗?
Ann N Y Acad Sci. 2000 Apr;903:252-61. doi: 10.1111/j.1749-6632.2000.tb06375.x.
10
A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia.一项关于85岁老年人血脑屏障功能的群体研究:与阿尔茨海默病和血管性痴呆的关系。
Neurology. 1998 Apr;50(4):966-71. doi: 10.1212/wnl.50.4.966.

引用本文的文献

1
Chia seeds as a potential cognitive booster in the APP23 Alzheimer's disease model.奇亚籽作为 APP23 阿尔茨海默病模型中的一种潜在认知增强剂。
Sci Rep. 2020 Oct 26;10(1):18215. doi: 10.1038/s41598-020-75209-z.
2
Levothyroxine treatment and incident dementia in adults with atrial fibrillation.左甲状腺素治疗与成人伴心房颤动患者的新发痴呆
Aging Clin Exp Res. 2020 Mar;32(3):433-439. doi: 10.1007/s40520-019-01217-3. Epub 2019 May 22.
3
Effect of Levothyroxine Treatment on Incident Dementia in Adults with Atrial Fibrillation and Hypothyroidism.
左甲状腺素治疗对伴发甲状腺功能减退的心房颤动患者新发痴呆的影响。
Clin Drug Investig. 2019 Feb;39(2):187-195. doi: 10.1007/s40261-018-0740-3.
4
A study on detection of glucose concentration using changes in color coordinates.一项关于利用颜色坐标变化检测葡萄糖浓度的研究。
Bioengineered. 2017 Jan 2;8(1):99-104. doi: 10.1080/21655979.2016.1227629. Epub 2016 Oct 24.
5
Relation of Blood Pressure to Cognitive Impairment and Dementia.血压与认知障碍和痴呆的关系。
Curr Hypertens Rev. 2007 Aug 1;3(3):166-176. doi: 10.2174/157340207781386747.
6
Is the distinction between Alzheimer's disease and vascular dementia possible and relevant?阿尔茨海默病与血管性痴呆之间的区别是否可行且具有相关性?
Dialogues Clin Neurosci. 2003 Mar;5(1):7-15. doi: 10.31887/DCNS.2003.5.1/rravonaspringer.
7
Cross currents in protein misfolding disorders: interactions and therapy.蛋白质错误折叠疾病中的交叉流:相互作用和治疗。
CNS Neurol Disord Drug Targets. 2009 Nov;8(5):363-71. doi: 10.2174/187152709789541998.
8
Cognitive dysfunction and diabetes mellitus.认知功能障碍与糖尿病
Endocr Rev. 2008 Jun;29(4):494-511. doi: 10.1210/er.2007-0034. Epub 2008 Apr 24.
9
Screening for cognitive impairment in older adults attending an eye clinic.对眼科门诊老年患者进行认知障碍筛查。
J Natl Med Assoc. 2005 Jun;97(6):808-14.
10
Co-morbidity associated with dementia.与痴呆症相关的共病
Am J Alzheimers Dis Other Demen. 2002 Mar-Apr;17(2):73-8. doi: 10.1177/153331750201700210.